James Knost, MD and Nancy Donini, RN OCN are Recent Graduates of the Intensive Course in Cancer Risk Assessment, Presented through the City of Hope

James Knost, MD and Nancy Donini, RN OCN are recent graduates of the Intensive Course in Cancer Risk Assessment, presented through the City of Hope Division of Clinical Cancer Genetics, Duarte, California. This annual CME/CEU-accredited multi-modal intensive course addresses the need for professional training in clinical cancer genetics and research collaboration for community-based clinicians.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend

Dr Knost

"We are extremely proud of both Dr. Knost and Ms. Donini for their completion of this extraordinary program. Participation is limited to a select number of individuals who are leaders in the field of Cancer Genetics.

Peoria, IL (PRWEB) April 10, 2013

James Knost, MD and Nancy Donini, RN OCN are recent graduates of the Intensive Course in Cancer Risk Assessment, presented through the City of Hope Division of Clinical Cancer Genetics, Duarte, California. This annual CME/CEU-accredited multi-modal intensive course addresses the need for professional training in clinical cancer genetics and research collaboration for community-based clinicians. Participants from around the world are selected and approved to participate in this elite 4-month program which accommodates the needs of participants with varied training backgrounds and practice settings. The training provided through City of Hope is recognized as the premier source of comprehensive, practice-focused cancer genetics-focused training anywhere. Coursework includes multidisciplinary didactics, interactive case conferencing, molecular genetics wet-lab and training in the use of informatics resources.

"We are extremely proud of both Dr. Knost and Ms. Donini for their completion of this extraordinary program," said Dr. Paul Fishkin, President, Illinois CancerCare, P.C. "Participation is limited to a select number of individuals who are leaders in the field of Cancer Genetics. Dr. Knost and Ms. Donini exemplify the character of our entire team at Illinois CancerCare and the commitment we all make to improving the quality of care for our patients and becoming the cancer genetics referral choice for this community."

City of Hope is recognized worldwide for its compassionate patient care, innovative science and translational research, which rapidly turns laboratory breakthroughs into promising new therapies. It is one of only 41 National Cancer Institute-designated Comprehensive Cancer Centers nationwide and is a founding member of the National Comprehensive Cancer Network.

About Illinois CancerCare:
Illinois CancerCare is one of the largest comprehensive private practices in the country that treats patients with cancer and blood diseases. Illinois CancerCare is central Illinois’ largest network of cancer care specialists with approximately 100 open clinical cancer research trials being conducted at any given time. The group has been recognized by the Quality Oncology Practice Initiative (QOPI®) Certification Program for outpatient hematology-oncology practices that meet the highest national standards for quality cancer care. Illinois CancerCare’s Community Clinical Oncology Program (CCOP) is one of the nation’s top enrollers in clinical trials, ranking 9tt in cancer clinical trials in the newly formed Alliance of Clinical Trials in Oncology. Illinois CancerCare has 17 physicians, 16 APN’s and more than 230 staff members. Illinois CancerCare serves patients from 25 counties through 13 clinics throughout central and western Illinois including Bloomington/Normal, Canton, Carthage, Eureka, Galesburg, Kewanee, Macomb, Monmouth, Ottawa, Pekin, Peoria, Peru and Princeton.

For further information please visit http://www.illinoiscancercare.com.
###


Contact

Attachments